Edition:
United States

G1 Therapeutics Inc (GTHX.OQ)

GTHX.OQ on NASDAQ Stock Exchange Global Select Market

20.33USD
3:59pm EST
Change (% chg)

$0.34 (+1.70%)
Prev Close
$19.99
Open
$20.16
Day's High
$20.44
Day's Low
$19.71
Volume
53,542
Avg. Vol
131,507
52-wk High
$69.23
52-wk Low
$15.21

Chart for

About

G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing small-molecule therapies for the treatment of cancer. Its two clinical-stage candidates are trilaciclib (G1T28) and G1T38, which are potent, selective inhibitors of the validated kinase targets CDK4/6. Trilaciclib and G1T38... (more)

Overall

Beta: --
Market Cap(Mil.): $731.75
Shares Outstanding(Mil.): 28.29
Dividend: --
Yield (%): --

Financials

  GTHX.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -1.88 -- --
ROI: -- 8.92 14.45
ROE: -- 10.08 15.96

Earnings vs. Estimates